pharma
Biogen stock surges following patent victory over Mylan for Tecfidera
February 6, 2020Sales and Marketing Biogen, Mylan, multiple sclerosis, pharma, tecfidera
Biogen has emerged victorious in a patent dispute with Mylan relating to the latter’s multiple sclerosis therapy Tecfidera – a …
Bayer’s Eylea shows strong vision benefits across two regimens in post-marketing study
February 5, 2020Research and Development Bayer, Eylea, pharma
Bayer has pulled back the curtain on new Phase 4 data for Eylea (aflibercept), revealing strong findings in the treatment …
Seqirus’ Audenz becomes first FDA-approved cell-based adjuvant influenza A vaccine
February 5, 2020Research and Development, Sales and Marketing FDA, influenza, pharma, seqirus
The FDA has just approved the first adjuvanted, cell-based vaccine for the prevention of influenza A (H5N1) in the US, …
Europe’s CHMP recommends Pfizer’s biosimilar of Roche’s MabThera
February 4, 2020Manufacturing and Production, Sales and Marketing MabThera, Pfizer, Ruxience, biosimilar, pharma
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has revealed that it has awarded a positive opinion for …
National Institutes of Health terminates HIV vaccine after it proves ineffective
February 4, 2020Manufacturing and Production HIV, pharma
A trial investigating the efficacy of a new HIV vaccine conducted by the National Institute of Allergy and Infectious Diseases …
Insider Interview: Reducing the risk of adverse cardiovascular events
February 3, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma
Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …
AbbVie’s Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic leukaemia
February 3, 2020Sales and Marketing AbbVie, CHMP, EMA, Venclyxto, pharma
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has awarded recommendation to AbbVie’s Venclyxto (venetoclax), …
NHS Chief Simon Stevens: Gwyneth Paltrow’s Goop poses “considerable risks to health”
January 31, 2020Medical Communications Goop, Gwyneth Platrow, NHS, Simon Stevens, pharma
NHS Chief Executive Simon Stevens has gone head-to-head with Hollywood actor and “wellness guru” Gwyneth Paltrow, taking aim at her …
Bayer and Orion’s Nubeqa shows off strong overall survival benefit in castration-resistant prostate cancer
January 31, 2020Medical Communications, Research and Development Bayer, orion, pharma
Bayer and Finnish pharma firm Orion Corporation have announced positive new Phase 3 data for their jointly developed oral androgen …
Read the January/February 2020 edition of Pharmafocus online now!
January 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma
Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …
Spring Bank Pharma shuts down HBV drug development following patient death
January 30, 2020Research and Development Spring Bank, patient death, pharma
Biopharma firm Spring Bank Pharmaceuticals has revealed it has taken the decision to terminate all further development of inarigivir soproxil …
Janssen’s Erleada expanded in Europe to cover metastatic hormone-sensitive prostate cancer
January 29, 2020Research and Development, Sales and Marketing Erleada, Europe, Janssen, pharma
Janssen’s Erleada (apalutamide) has secured expanded authorisation from the European Commission (EC), approving its label to include the treatment of …
FDA approves Teva’s Ajovy autoinjector for treatment of migraine
January 29, 2020Research and Development, Sales and Marketing FDA, Teva, ajovy, migraine, pharma
Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …
Lilly & Incyte’s Olumiant hits main goal in atopic dermatitis
January 28, 2020Manufacturing and Production, Research and Development Eli Lilly, Olumiant, pharma
Eli Lilly and Incyte have lifted the curtain on new Phase 3 data showing that their oral JAK inhibitor, showing …
Realising the potential of greater collaboration for women living with cancer
January 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Merck KGaA, feature, pharma, women
Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
